炎症性肠病中痔病的外科治疗:一项采用比例Meta分析的系统评价
Surgical Management of Hemorrhoidal Disease in Inflammatory Bowel Disease: A Systematic Review with Proportional Meta-Analysis.
作者信息
Grossi Ugo, Gallo Gaetano, Di Tanna Gian Luca, Bracale Umberto, Ballo Mattia, Galasso Elisa, Kazemi Nava Andrea, Zucchella Martino, Cinetto Francesco, Rattazzi Marcello, Felice Carla, Zanus Giacomo
机构信息
II Surgery Unit, Regional Hospital Treviso, AULSS2, 31100 Treviso, Italy.
Department of Surgery, Oncology and Gastroenterology-DISCOG, University of Padua, 35128 Padua, Italy.
出版信息
J Clin Med. 2022 Jan 28;11(3):709. doi: 10.3390/jcm11030709.
Surgical treatment of hemorrhoidal disease (HD) in inflammatory bowel disease (IBD) has been considered to be potentially harmful, but the evidence for this is poor. Therefore, a systematic review of the literature was undertaken to reappraise the safety and effectiveness of surgical treatments in this special circumstance. A MEDLINE, Web of Science, Scopus, and Cochrane Library search was performed to retrieve studies reporting the outcomes of surgical treatment of HD in patients with Crohn's disease (CD) and ulcerative colitis (UC). From a total of 2072 citations, 10 retrospective studies including 222 (range, 2-70) patients were identified. Of these, 119 (54%) had CD and 103 (46%) UC. Mean age was between 41 and 49 years (range 14-77). Most studies lacked information on the interval between surgery and the onset of complications. Operative treatments included open or closed hemorrhoidectomy ( = 156 patients (70%)), rubber band ligation ( = 39 (18%)), excision or incision of thrombosed hemorrhoid ( = 14 (6%)), and doppler-guided hemorrhoidal artery ligation (DG-HAL, = 13 (6%)). In total, 23 patients developed a complication (pooled prevalence, 9%; (95%CI, 3-16%)), with a more than two-fold higher rate in patients with CD compared to UC (11% (5-16%) vs. 5% (0-13%), respectively). Despite the low quality evidence, surgical management of HD in IBD and particularly in CD patients who have failed nonoperative therapy should still be performed with caution and limited to inactive disease. Further studies should determine whether advantages in terms of safety and effectiveness with the use of non-excisional techniques (e.g., DG-HAL) can be obtained in this patient population.
炎症性肠病(IBD)患者痔病(HD)的手术治疗一直被认为可能有害,但相关证据不足。因此,我们对文献进行了系统回顾,以重新评估这种特殊情况下手术治疗的安全性和有效性。我们检索了MEDLINE、科学网、Scopus和考克兰图书馆,以获取报告克罗恩病(CD)和溃疡性结肠炎(UC)患者HD手术治疗结果的研究。在总共2072篇文献中,我们确定了10项回顾性研究,共222例(范围为2 - 70例)患者。其中,119例(54%)患有CD,103例(46%)患有UC。平均年龄在41至49岁之间(范围为14 - 77岁)。大多数研究缺乏手术与并发症发生间隔时间的信息。手术治疗包括开放式或封闭式痔切除术(n = 156例患者(70%))、橡皮圈套扎术(n = 39例(18%))、血栓性外痔切除术或切开术(n = 14例(6%))以及多普勒引导下痔动脉结扎术(DG - HAL,n = 13例(6%))。总共有23例患者出现并发症(合并患病率为9%;(95%CI,3 - 16%)),CD患者的并发症发生率比UC患者高出两倍多(分别为11%(5 - 16%)和5%(0 - 13%))。尽管证据质量较低,但IBD患者HD的手术治疗,尤其是非手术治疗失败的CD患者,仍应谨慎进行,且仅限于疾病静止期。进一步的研究应确定在该患者群体中使用非切除技术(如DG - HAL)是否能在安全性和有效性方面获得优势。
相似文献
Tech Coloproctol. 2021-12
Inflamm Bowel Dis. 2020-8-20
Colorectal Dis. 2014-7
Int J Colorectal Dis. 2021-11
Jpn J Gastroenterol Hepatol. 2020
Cochrane Database Syst Rev. 2018-11-13
Cochrane Database Syst Rev. 2019-2-8
引用本文的文献
World J Gastrointest Surg. 2024-5-27
World J Clin Cases. 2022-7-6
本文引用的文献
Acta Gastroenterol Belg. 2021
Nat Rev Gastroenterol Hepatol. 2021-1
GE Port J Gastroenterol. 2020-2
Colorectal Dis. 2020-6
Inflamm Bowel Dis. 2020-8-20